An early-stage clinical trial of an experimental Ebola vaccine found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses in all 40 of the healthy adults who received it.
Suscribirse a:
Enviar comentarios (Atom)
A word from the editor, news, information, reviews
No hay comentarios:
Publicar un comentario